Page 50 - Read Online

Chandrasekar et al. Mini-invasive Surg 2021;5:33 https://dx.doi.org/10.20517/2574-1225.2021.12 Page 13 of 16

Availability of data and material
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Both authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8. DOI
PubMed PMC
2. Ebata T, Kosuge T, Hirano S, et al. Proposal to modify the International Union Against Cancer staging system for perihilar
cholangiocarcinomas. Br J Surg 2014;101:79-88. DOI PubMed
3. Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the
rise. Oncologist 2016;21:594-9. DOI PubMed PMC
4. Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015;29:221-32. DOI PubMed
5. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84. DOI PubMed PMC
6. Singh A, Gelrud A, Agarwal B. Biliary strictures: diagnostic considerations and approach. Gastroenterol Rep (Oxf) 2015;3:22-31.
DOI PubMed PMC
7. Albu S, Tanţǎu M, Spârchez Z, et al. Diagnosis and treatment of extrahepatic cholangiocarcinoma: results in a series of 124 patients.
Rom J Gastroenterol 2005;14:33-6. PubMed
8. Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT.
Radiology 2005;236:178-83. DOI PubMed
9. Ruys AT, Ven Beem BE, Engelbrecht MRW, et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review
and meta-analysis. Br J Radiol 2012;85:1255-62. DOI
10. Zhang H, Zhu J, Ke F, et al. Radiological imaging for assessing the respectability of Hilar cholangiocarcinoma: a systematic review
and meta-analysis. Biomed Res Int 2015;2015:497942. DOI PubMed PMC
11. Vanderveen KA, Hussain HK. Magnetic resonance imaging of cholangiocarcinoma. Cancer Imaging 2004;4:104-15. DOI PubMed
PMC
12. Yeh TS, Jan YY, Tseng JH, et al. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am
J Gastroenterol 2000;95:432-40. DOI PubMed
13. Elias Y, Mariano AT Jr, Lu Y. Detection of primary malignancy and metastases with FDG PET/CT in patients with
cholangiocarcinomas: lesion-based comparison with contrast enhanced CT. World J Nucl Med 2016;15:161-6. DOI PubMed PMC
14. Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions
in patients with biliary cancer. J Am Coll Surg 2008;206:57-65. DOI PubMed
15. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients
without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204-7. DOI PubMed
16. Malaguarnera G, Paladina I, Giordano M, Malaguarnera M, Bertino G, Berretta M. Serum markers of intrahepatic
cholangiocarcinoma. Dis Markers 2013;34:219-28. DOI PubMed PMC
17. Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer:
analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999;94:1941-6. DOI PubMed
18. Ramage JK, Donaghy A, Farrant J, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary
sclerosing cholangitis. Gastroenterology 1995;108:865-9. DOI PubMed
19. Alvarez Herrero L, Curvers WL, van Vilsteren FG, et al. Validation of the Prague C&M classification of Barrett's esophagus in clinical
practice. Endoscopy 2013;45:876-82. DOI PubMed
20. Vedeld HM, Folseraas T, Lind GE. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of
DNA methylation and molecular biomarkers. JHEP Rep 2020;2:100143. DOI PubMed PMC